Directed modification instead of normalization of fatty acid patterns in cystic fibrosis: An emerging concept

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 4, Issue 2, 2001, Pages 111-113

  Christophe, Armand ^a   Robberecht, Eddy ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL;

CYSTIC FIBROSIS; DIET SUPPLEMENTATION; FAT INTAKE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; PHOSPHOLIPID METABOLISM; SHORT SURVEY;

ANIMALS; CYSTIC FIBROSIS; DOCOSAHEXAENOIC ACIDS; EICOSANOIDS; FATTY ACIDS; HUMANS; MICE; NUTRITIONAL STATUS;

EID: 0035744756     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200103000-00005     Document Type: Short Survey

References (13)

1. Current knowledge on fatty acids in cystic fibrosis
2. Prostanoid biosynthesis in patients with cystic fibrosis
3. Pathological regulation of arachidonic acid release in cystic fibrosis: The putative basic defect
4. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis
5. Increase of bradykinin-stimulated arachidonic acid release in a delta-F508 cystic fibrosis epithelial cell line
6. Cystic fibrosis gene mutation is associated with an intrinsic abnormality in Ca2+-induced arachidonic acid release by epithelial cells
7. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients
8. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr-/-mice
9. Increase of long chain omega-3 fatty acids in the major serum lipid classes of patient swith cystic fibrosis
10. Effect of administration of gamma-linolenic acid on the fatty acid composition of serum phospholipids and cholesteryl esters in patients with cystic fibrosis
11. Clinical biochemistry of EFAs
12. Extensive absorption of the organised lipid matrix, Lym-x-sorb, by CF patients and better clinical outcomes following a one year controlled trial